SSWM
MRNA icon

Sheets Smith Wealth Management’s Moderna MRNA Stock Holding History

Sheets Smith Wealth Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,479
Closed -$227K – 339
2023
Q1 		$227K Hold
1,479
– – 0.03% 289
2022
Q4 		$266K Buy
+1,479
New +$242K 0.04% 267
2022
Q3 		– Sell
-1,479
Closed -$211K – 308
2022
Q2 		$211K Hold
1,479
– – 0.03% 283
2022
Q1 		$255K Sell
1,479
-2,300
-61% -$387K 0.04% 300
2021
Q4 		$960K Sell
3,779
-21
-0.6% -$6.14K 0.12% 158
2021
Q3 		$1.46M Hold
3,800
– – 0.2% 118
2021
Q2 		$893K Hold
3,800
– – 0.12% 152
2021
Q1 		$498K Buy
3,800
+1,100
+41% +$159K 0.07% 208
2020
Q4 		$282K Buy
+2,700
New +$273K 0.04% 284

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Sheets Smith Wealth Management's MRNA Position: Q2 2023 in Review

Sheets Smith Wealth Management sold out of Moderna (MRNA) in Q2 2023, closing a stake of 1,479 shares — an estimated $227K sold.

Sheets Smith Wealth Management first reported a position in MRNA in Q4 2020 and held it in 9 quarters. The position peaked at $1.46M in Q3 2021. 965 funds tracked by Wall St. Rank hold MRNA as of Q2 2023.

  • Sheets Smith Wealth Management reported no remaining Moderna position as of Q2 2023 after selling out during the quarter.
  • Sheets Smith Wealth Management sold 1,479 Moderna shares in Q2 2023, an estimated $227K.
  • Sheets Smith Wealth Management first reported a position in Moderna in Q4 2020 and held it in 9 quarters.
  • Sheets Smith Wealth Management's Moderna position peaked at $1.46M in Q3 2021.
  • 965 funds tracked by Wall St. Rank held Moderna as of Q2 2023.

Based on Sheets Smith Wealth Management's 13F filing for Q2 2023, filed 9 Aug 2023.